Emerge™ H7493918908300Recalls & reported problems
Boston Scientific Corporation · PTCA Dilatation Catheter · Class 2
All models of Emerge (54)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729806547), received between Sep 10, 2018 and Jan 5, 2024 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Break1
- Failure to Deflate1
- Material Rupture1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
- No Known Impact Or Consequence To Patient1
- No Patient Involvement1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 5, 2024Failure to Deflate; Failure to Deflate
IT WAS REPORTED THAT BALLOON DEFLATION ISSUE OCCURRED. A 3.00MM X 8MM EMERGE BALLOON CATHETER WAS USED IN A PERCUTANEOUS CORONARY INTERVENTION; HOWEVER, DEFLATION ISSUE WAS NOTED. THE DEVICE WAS REPLACED, AND THE PROCEDURE WAS COMPLETED WITH NO PATIENT COMPLICATIONS NOR INJURIES REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18450062 ↗MalfunctionOct 25, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 04OCT2018. THIS 3.00MM X 8MM EMERGE BALLOON CATHETER WAS RECEIVED WITH NO REPORTED ISSUES. HOWEVER, RETURNED DEVICE ANALYSIS REVEALED SEPARATED HYPOTUBE. DEVICE EVALUATED BY MANUFACTURER: THE RETURNED PRODUCT CONSISTED OF AN EMERGE BALLOON CATHETER. THE OUTER SHAFT, INNER SHAFT, BALLOON AND TIP WERE VISUALLY AND MICROSCOPICALLY EXAMINED. VISUAL EXAMINATION REVEALED MULTIPLE KINKS ALONG THE HYPOTUBE. THE HYPOTUBE IS SEPARATED 79.6CM FROM THE HUB. MICROSCOPIC EXAMINATION REVEALED THAT THE TIP IS DAMAGED AND THE BALLOON IS LOOSE. THERE IS BLOOD PRESENT IN THE HUB, INFLATION LUMEN, AND BALLOON. THE BROKEN SHAFT WAS CONNECTED TO A TUOHY ADAPTER AND STOPCOCK THEN INFLATED USING A BALLOON INFLATION DEVICE TO CHECK FOR POSSIBLE DAMAGES TO THE BALLOON. THE BALLOON WAS INFLATED TO RBP OF 14ATM AND COULD HOLD PRESSURE FOR 5 MINUTES BEFORE IT WAS DEFLATED. INSPECTION OF THE REMAINDER OF THE DEVICE PRESENTED NO OTHER DAMAGE OR IRREGULARITIES.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8005690 ↗MalfunctionSep 25, 2018Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. DURING PREPARATION OF THE DEVICE, THE PHYSICIAN TOOK THE BALLOON OUT OF THE LOOP IN THE HYPOTUBE. IT WAS NOTICED THAT THE SHAFT SEPARATED WHERE THE HYPOTUBE MEETS THE BALLOON. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE, NO PATIENT COMPLICATIONS NOR INJURIES WERE REPORTED.
Patient problems: No Patient Involvement
MAUDE report 7906161 ↗MalfunctionSep 10, 2018Material Rupture; Material Rupture
IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE TARGET LESION WAS LOCATED IN A HEAVILY CALCIFIED VESSEL. A 3.00MM X 8MM EMERGE BALLOON CATHETER WAS ADVANCED FOR DILATATION. HOWEVER, THE BALLOON MATERIAL WAS TORN IN THE PROCESS. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7862427 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page